Pulsatile Pulmonary Perfusion During Cardiopulmonary Bypass Reduces the Pulmonary Inflammatory Response

Annals of Thoracic Surgery

Volumn 86, Issue 1, 2008, Pages 115-122

  Siepe, Matthias ^a   Goebel, Ulrich ^a   Mecklenburg, Anne ^a   Doenst, Torsten ^a   Benk, Christoph ^a   Stein, Philipp ^a   Beyersdorf, Friedhelm ^a   Loop, Torsten ^a   Schlensak, Christian ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; INTERLEUKIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; INFLAMMATION; LUNG PERFUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSATILE FLOW; RANDOMIZATION; SWINE; ANIMAL; DISEASE MODEL; HEMODYNAMICS; INJURY; LUNG; LUNG GAS EXCHANGE; METHODOLOGY; MULTIVARIATE ANALYSIS; PEROPERATIVE CARE; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROBABILITY; REFERENCE VALUE; REPERFUSION INJURY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VASCULARIZATION;

ANIMALS; CARDIOPULMONARY BYPASS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMODYNAMICS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKINS; INTRAOPERATIVE CARE; LUNG; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PULMONARY GAS EXCHANGE; PULSATILE FLOW; RANDOM ALLOCATION; REFERENCE VALUES; REPERFUSION INJURY; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47049126237     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.03.062     Document Type: Article

References (23)

1. Ng C.S., Wan S., Yim A.P., and Arifi A.A. Pulmonary dysfunction after cardiac surgery. Chest 121 (2002) 1269-1277
2. Fitch J.C., Rollins S., Matis L., et al. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation 100 (1999) 2499-2506
3. Schlensak C., Doenst T., Preusser S., Wunderlich M., Kleinschmidt M., and Beyersdorf F. Bronchial artery perfusion during cardiopulmonary bypass does not prevent ischemia of the lung in piglets: assessment of bronchial artery blood flow with fluorescent microspheres. Eur J Cardiothorac Surg 19 (2001) 326-331
4. Morse D., Pischke S.E., Zhou Z., et al. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 278 (2003) 36993-36998
5. Massoudy P., Zahler S., Becker B.F., Braun S.L., Barankay A., and Meisner H. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest 119 (2001) 31-36
6. Kotani T., Kotake Y., Morisaki H., et al. Activation of a neutrophil-derived inflammatory response in the airways during cardiopulmonary bypass. Anesth Analg 103 (2006) 1394-1399
7. Schlensak C., and Beyersdorf F. Lung injury during CPB: pathomechanisms and clinical relevance. Interact Cardiovasc Thorac Surg 4 (2005) 381-382
8. Ashraf S., Tian Y., Cowan D., Entress A., Martin P.G., and Watterson K.G. Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators. Ann Thorac Surg 64 (1997) 1790-1794
9. Royston D., Levy J.H., Fitch J., et al. Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes. Anesth Analg 103 (2006) 1082-1088
10. Koul B., Willen H., Sjoberg T., Wetterberg T., Kugelberg J., and Steen S. Pulmonary sequelae of prolonged total venoarterial bypass: evaluation with a new experimental model. Ann Thorac Surg 51 (1991) 794-799
11. Jaggers J.J., Forbess J.M., Shah A.S., et al. Extracorporeal membrane oxygenation for infant postcardiotomy support: significance of shunt management. Ann Thorac Surg 69 (2000) 1476-1483
12. Quaniers J.M., Leruth J., Albert A., Limet R.R., and Defraigne J.O. Comparison of inflammatory responses after off-pump and on-pump coronary surgery using surface modifying additives circuit. Ann Thorac Surg 81 (2006) 1683-1690
13. Staton G.W., Williams W.H., Mahoney E.M., et al. Pulmonary outcomes of off-pump vs on-pump coronary artery bypass surgery in a randomized trial. Chest 127 (2005) 892-901
14. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 (2004) 205-209
15. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (1999) 6853-6866
16. Wisdom R. AP-1: one switch for many signals. Exp Cell Res 253 (1999) 180-185
17. Naidu B.V., Krishnadasan B., Farivar A.S., et al. Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 126 (2003) 200-207
18. Park G.Y., and Christman J.W. Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease. Curr Drug Targets 7 (2006) 661-668
19. Chen Y., Voegeli T.S., Liu P.P., Noble E.G., and Currie R.W. Heat shock paradox and a new role of heat shock proteins and their receptors as anti-inflammation targets. Inflamm Allergy Drug Targets 6 (2007) 91-100
20. Alghamdi A.A., and Latter D.A. Pulsatile versus nonpulsatile cardiopulmonary bypass flow: an evidence-based approach. J Card Surg 21 (2006) 347-354
21. Murkin J.M., Martzke J.S., Buchan A.M., Bentley C., and Wong C.J. A randomized study of the influence of perfusion technique and pH management strategy in 316 patients undergoing coronary artery bypass surgery. I. Mortality and cardiovascular morbidity. J Thorac Cardiovasc Surg 110 (1995) 340-348
22. Saito S., and Nishinaka T. Chronic nonpulsatile blood flow is compatible with normal end-organ function: implications for LVAD development. J Artif Organs 8 (2005) 143-148
23. Sievers H.H., Freund-Kaas C., Eleftheriadis S., et al. Lung protection during total cardiopulmonary bypass by isolated lung perfusion: preliminary results of a novel perfusion strategy. Ann Thorac Surg 74 (2002) 1167-1172